Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Astrocytoma × vorasidenib × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 2 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 9 Radiotherapy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 Bevacizumab 3 Radiation 2 Genetic Therapy 2 Fluorodeoxyglucose F18 2 vorasidenib 1 trastuzumab deruxtecan 1 trametinib 1 ribociclib 1 regorafenib 1 pembrolizumab 1 olutasidenib 1 lorlatinib 1 aflibercept 1 abexinostat 1 Vinblastine 1 Tretinoin 1 Therapies, Investigational 1 Surgical Procedures, Operative 1 Restraint, Physical 1 Re-Irradiation 1 Radiotherapy, Intensity-Modulated 1 Pluvicto 1 Paclitaxel 1 Oncolytic Virotherapy 1 ONC206 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06809322 2026-02-17

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡